SINSIN MULPAS

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
SINSIN MULPAS
Generic name
L-MENTHOL, METHYL SALICYLATE, DL-CAMPHOR, CHLORPHENIRAMINE MALEATE, THYMOL
Manufacturer
Sinsin Pharmaceutical Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
81baffcb-c08e-4616-e053-2a91aa0aaf15
SPL ID
4096c7d0-3f62-3567-e063-6294a90abd4a
Version
9
Effective date
2025-10-07
Source export date
2026-09-28
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:47:58
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use on wounds or damaged skin if you are allergic to any ingredients of this product with a heating pad with, or at the same time as, other external analgesic products When using this product do not use otherwise than directed avoid contact with eyes, mucous membranes or rashes do not bandage tightly Ask a doctor before use if you are prone to allergic reaction from aspirin or salicylates Stop use and ask a doctor if rash, itching, or excessive skin irritation develops conditions worsen symptoms persist for more than 7 days symptoms clear up and occur again within a few days If pregnant or breast-feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.